Annual Meeting – Featured Speakers

Sunday, August 12 at 5 pm

Jay Keasling - Annual Meeting 2012 KeynoteJay Keasling
Hubbard Howe Distinguished Professor of Biochemical Engineering, University of California, Berkeley
Title: Synthetic Biology for Synthetic Fuels
When: Sunday, August 12 at 5 pm

Jay Keasling received his B.S. in Chemistry and Biology from the University of Nebraska in 1986; his Ph. D. in Chemical Engineering from the University of Michigan in 1991; and did post-doctoral work in Biochemistry at Stanford University from 1991-1992. Keasling joined the Department of Chemical Engineering at the University of California, Berkeley as an assistant professor in 1992, where he is currently the Hubbard Howe Distinguished Professor of Biochemical Engineering. Keasling is also a professor in the Department of Bioengineering at Berkeley, a Sr. Faculty Scientist and Associate Laboratory Director of the Lawrence Berkeley National Laboratory and Chief Executive Officer of the Joint BioEnergy Institute. Dr. Keasling’s research focuses on engineering microorganisms for environmentally friendly synthesis of small molecules or degradation of environmental contaminants. Keasling’s laboratory has engineered bacteria and yeast to produce polymers, a precursor to the anti-malarial drug artemisinin, and advanced biofuels and soil microorganisms to accumulate uranium and to degrade nerve agents.

Banquet Guest Speaker
Tuesday, August 14 at 7 pm

Geoff DuykGeoff Duyk, M.D., Ph.D.
Partner and Managing Director, TPG Biotechnology
Title: Second derivative thinking- reworking the CleanTech investment Thesis
When: Tuesday, August 14 at 7 pm

Dr. Duyk co-leads TPG Biotechnology group managing $1.1 bn in capital and is the lead partner in TPG’s Alternative and Renewable Technology sector. Prior to joining TPG Biotech in 2004, Dr. Duyk served on the Board of Directors and was President of Research & Development at Exelixis where he led a 550+ person group focused on the discovery and development of small molecule therapeutics.  Prior to Exelixis, he was one of the founding scientific staff at Millennium Pharmaceuticals.  As Vice President of Genomics at Millennium, Dr. Duyk was responsible for building and leading the informatics, automation, DNA sequencing and genotyping groups as well as the mouse and human genetics group.

Prior to his tenure at Millennium, Dr. Duyk was an Assistant Professor at Harvard Medical School (HMS) in the Department of Genetics and Assistant Investigator of the Howard Hughes Medical Institute (HHMI).  While at HMS, he was a Co-Principal Investigator in the National Institutes of  Health (NIH) funded Cooperative Human Linkage Center.  Dr. Duyk has been and continues to be a member of numerous NIH panels and oversight committees focused on the planning and execution of the Human Genome Project.

Dr. Duyk holds a Ph.D. and M.D. from Case Western Reserve University and completed his medical and fellowship training at University of  California, San Francisco. While at UCSF, Dr. Duyk was a fellow of the Lucille P. Markey Foundation and was also awarded a post-doctoral fellowship from the Howard Hughes Medical Institute. Dr. Duyk completed his post-doctoral and clinical training at UCSF and received his BA from Wesleyan University.

Charles Thom Award Lecture 2012

Sang Yup LeeSang Yup Lee
Distinguished Professor and Dean of College of Life Science and Bioengineering at KAIST
When: Thursday, August 16 at 1 pm
Title: Microbial production of natural and non-natural chemicals through inherent, noninherent, and created pathways

Sang Yup Lee received B.S. in Chem. E. from Seoul National University in 1986, and Ph.D. in Chem. E. from Northwestern University in 1991. Currently, he is Distinguished Professor and Dean of College of Life Science and Bioengineering at KAIST. He is also the Director of Center for Systems and Synthetic Biotechnology, Director of BioProcess Engineering Research Center, and Director of Bioinformatics Research Center. He has published more than 400 journal papers, and numerous patents. He received many awards, including the National Order of Merit, Citation Classic Award, Elmer Gaden Award, and Merck Metabolic Engineering Award. He is currently Fellow of AAAS, American Academy of Microbiology, Society for Industrial Microbiology and Biotechnology, Korean Academy of Science and Technology, and National Academy of Engineering of Korea. He is also Foreign Associate of National Academy of Engineering USA, Editor-in-Chief of Biotechnology Journal, and editor and board member of many journals. His research interests are metabolic engineering, systems and synthetic biology, and industrial biotechnology.

SIMB Industry Award Lecture 2012

MedImmuneRaghavan Venkat
Senior Director, Research & Development, MedImmune
When: Monday, August 13, 4:30 – 5:30 p.m.
Title: Process Innovation – Enabling force for Product Innovation at MedImmune

Raghavan Venkat is currently Senior Director, R&D, and leads the Process Cell Culture and Fermentation team within MedImmune.  Raghavan obtained his B.Tech. degree in Chemical Engineering at Anna University, Chennai, India and his M.S. and Ph.D. degrees in Chemical Engineering at The Ohio State University, in the US. Raghavan has worked in the biopharmaceutical industry for over 16 years and has been with MedImmune for over 6 years.

Raghavan’s expertise is in the field of biopharmaceutical development with an emphasis on protein expression, cell biology and scale-up of biologics production processes.  Raghavan is also very active in the biotechnology research community and has chaired and presented at multiple international meetings. He was most recently the program chair of the BIOT division at the American Chemical Society National Meeting held in Anaheim, CA in March 2011.

MedImmune is the 2012 recipient of the SIMB Industry Award for Discovery, Innovation and Development in Industrial Microbiology and Biotechnology. Learn more.